Attention deficit disorder: evaluation and treatment.
Dulcan
M K
MK
D000367:Age Factors; D000855:Anorexia / Q000139:chemically induced; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis / Q000188:drug therapy* / Q000628:therapy; D001521:Behavior Therapy; D001827:Body Height / Q000187:drug effects; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D003071:Cognition / Q000187:drug effects; D003913:Dextroamphetamine / Q000494:pharmacology; D006321:Heart / Q000187:drug effects; D006801:Humans; D007398:Interpersonal Relations; D007700:Kinetics; D008774:Methylphenidate / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D010389:Pemoline / Q000494:pharmacology; D013268:Stimulation, Chemical; D005879:Tourette Syndrome / Q000139:chemically induced
D000697:Central Nervous System Stimulants; D008774:Methylphenidate; D010389:Pemoline; D003913:Dextroamphetamine